Delivery Order SPE2DB20D1110-SPE2DB24FK04A
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX medication. The award, valued at $11,642.60, has a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX. The $11,642.60 contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order as well as an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 200 unit vials of Botox. The firm-fixed-price contract is valued at $3,492.78 and has a period of performance through July 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA)...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,821.30 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,594,222 units of BOTOX 200 unit vials. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $58,213 contract is for the delivery of 200-unit vials of BOTOX medication to support military treatment programs and facilities. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 200 unit vials of BOTOX. The $3,492.78 contract has a completion date of March 12, 2024 and was awarded on February 20, 2024. AmerisourceBergen Drug Corp serves as a prime contractor to DLA, delivering pharmaceutical products and medical supplies to military treatment programs and facilities...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 200 unit vials of BOTOX. This $29,106.50 contract has a completion date of March 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,985.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200-unit vials of the pharmaceutical product Botox. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $61,123.65 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,563,523,377 units of BOTOX 200 unit vials, with a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FK04ADelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide BOTOX 200 unit vials. The $3,492.78 order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation and serves as a prime contractor to DLA, providing a range of pharmaceutical products and medical supplies in support of military treatment programs and facilities. This order is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver medications and healthcare materials to DLA Troop Support Medical under the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 3/18/24 |